Four out of five top stories in infectious disease last week were about updates on COVID-19 vaccination.

Clinicians should consider the heterogeneity of psoriatic arthritis when selecting therapeutic options, according to a speaker at the ACR State-of-the-Art Clinical Symposium.

More than 40% of older adults in the United States said they utilized online ratings or reviews when choosing their doctor, according to survey data published in Annals of Internal Medicine.

While many of the forthcoming American College of Rheumatology guidelines for rheumatoid arthritis capture the reality of clinical practice, some recommendations are “puzzling,” according to a speaker at the ACR State-of-the-Art Clinical Symposium.

Adults aged over 65 years who took thiazides for hypertension had an increased risk for keratinocyte carcinoma and melanoma, according to results of a population-based cohort study.

The FDA has approved a self-injectable formulation of Xolair for appropriate patients with moderate to severe persistent allergic asthma, nasal polyps or chronic idiopathic urticaria, according to the manufacturers.

Although it took a bit longer than expected, the first FDA approval of a chimeric antigen receptor T-cell therapy for advanced multiple myeloma will have a major impact on clinical practice, according to experts.

There are many IOL options for aphakia without capsular support, one being the angle-supported open-loop flexible anterior chamber IOL. Whether it should a hold a place in the pediatric surgeon’s armamentarium is debatable.

Results of a three-armed trial demonstrated that dolutegravir-based ART regimens are favorable to efavirenz-based regimens among pregnant women with HIV, according to data presented recently at the Conference on Retroviruses and Opportunistic Infections.

Blue Cross and Blue Shield of Minnesota announced it will partner with DaVita Inc. to launch its integrated kidney care VillageHealth program in the Blue Cross Minnesota network.